Barcelona, Spain
15-19 March 2019
15-19 March 2019
M. Albersen
Leuven (BE)
F. Hamdy
Oxford (GB)
G. Simone
Rome (IT)
F. Montorsi
Milan (IT)
V. Kasivisvanathan
London (GB)
P. Alken
Mannheim (DE)
Karl Storz
Accepted by Mrs Sybill Storz on behalf of the company
15-19 March 2019
Barcelona, Spain
10,879 participants
5461 abstracts submitted, 1681 accepted
53 ESU Courses and 45 ESU Hands-on Training courses
21-25 March 1998
F. Sole Balcells,
Barcelona (ES)
F. Montorsi,
Milan (IT)
21-25 March 1998
Barcelona, Spain
5,300 participants
Over 1,700 abstracts submitted
8 ESU Courses
Continuous Internet access was made available
The first time abstracts were recorded on CD
From a biennial meeting, the EAU Congress becomes an annual event. The Opening Ceremony took place with Juan Antonio Samaranch Torelló as special guest. Samaranch Torelló, Marquess of Samaranch, served as the 7th President of the International Olympic Committee (IOC) from 1980 to 2001. The organisation from that moment on is entirely in the hands of the congress Department of the EAU Central Office.
16-20 April 2010
F.M.J. Debruyne,
Nijmegen (NL)
J.W.F. Catto,
Sheffield (GB)
R. Vela Navarrete,
Madrid (ES)
16-20 April 2010
Barcelona, Spain
10.660 registered participants
3,800 abstract submitted, 1054 accepted
38 ESU Courses organised
25th Anniversary EAU Congress
For the first time high visitor numbers were registered or viewed the live webcasts at the EAU’s www.uroweb.org. Recordings of the plenary sessions, debates, lectures, courses and workshops were posted live. Statistics on the website indicated a surge in visitors numbers and page hits even up to the first week of May.
The European Organisation for Research and Treatment of Cancer (EORTC) 30904 study released its findings during the Breaking News session which showed that conservative surgery is not inferior to radical renal surgery or nephrectomy. “Few patients progressed during the study, nine in the radical arm and 12 in the conservative arm,” said Prof. Hein van Poppel who issued the EORTC results during the plenary session on kidney cancer.